Publications

November 2024
Article

Preference Externality Estimators: A Comparison of Border Approaches and IVs

By: Xi Ling, Wesley R. Hartmann and Tomomichi Amano

This paper compares two estimators—the Border Approach and an Instrumental Variable (IV) estimator—using a unified framework where identifying variation arises from “preference externalities,” following the intuition in Waldfogel (2003). We highlight two dimensions in... View Details

Keywords: Econometrics; Casual Inference; Marketing; Economics; Advertising; Mathematical Methods

September–October 2020
Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern

Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details

Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change

Find at Harvard

01 Jun 2011
Working Paper Summaries

The First Deal: The Division of Founder Equity in New Ventures

Keywords: by Thomas F. Hellmann & Noam Wasserman

2020
Working Paper

Targeting for Long-Term Outcomes

By: Jeremy Yang, Dean Eckles, Paramveer Dhillon and Sinan Aral

Decision makers often want to target interventions so as to maximize an outcome that is observed only in the long term. This typically requires delaying decisions until the outcome is observed or relying on simple short-term proxies for the long-term outcome. Here we... View Details

Keywords: Targeted Marketing; Optimization; Churn Management; Marketing; Customer Relationship Management; Policy; Learning; Outcome or Result

10 Feb 2016
HBS Seminar

Chris Blattman, Associate Professor, Columbia SIPA

January 2020
Article

The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz

Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details

Keywords: Medical Devices; Health Testing and Trials; Analysis; Sales

14 Nov 2017
First Look

New Research and Ideas: November 14, 2017

through three examples: the design of medical residency matching programs, a scrip system to allocate food donations to food banks, and the recent "Incentive Auction" that reallocated wireless spectrum from television broadcasters to telecoms. Our lead examples show... View Details

Keywords: Carmen Nobel

Forthcoming
Book

Innovating in Healthcare: Creating Breakthrough Tech, Services, Drugs, Products, and Business Models

By: Regina E. Herzlinger

Innovating in Healthcare offers effective approaches for designing, reworking, and implementing innovative healthcare services, products, and business models. It will help anyone working in healthcare service or product development, from hospitals to startups,... View Details

Keywords: Health Care and Treatment; Service Delivery; Product Development; Business Model; Innovation and Invention; Health Industry

October 2005 (Revised October 2008)
Case

Virginia Mason Medical Center

By: Richard M.J. Bohmer and Erika Ferlins

In 2000, Dr. Gary Kaplan became CEO of the Virginia Mason Medical Center in Seattle, Washington. The hospital was facing significant challenges: It was losing money for the first time in its history, staff morale had plummeted, and area hospitals presented ardent... View Details

Keywords: Health Care and Treatment; Management Analysis, Tools, and Techniques; Production; Organizational Change and Adaptation; Problems and Challenges; Quality; Competition; Seattle

02 Oct 2015
Working Paper Summaries

Is Mandatory Nonfinancial Performance Measurement Beneficial?

Keywords: by Susanna Gallani, Takehisha Kajiwara & Ranjani Krishnan; Health

March 2020
Case

Maven Clinic: Women's Health in the Digital Age

By: Ariel D. Stern and Sarah Mehta

In late 2017, Kate Ryder, the founder and CEO of digital women’s health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners... View Details

Keywords: Business Growth and Maturation; Business Model; Business Startups; Entrepreneurship; Health; Health Care and Treatment; Strategy; Information Technology; Applications and Software; Health Industry; Technology Industry; United States

Article

Value of New Performance Information in Healthcare: Evidence from Japan

By: Susanna Gallani, Takehisa Kajiwara and Ranjani Krishnan

Mandatory measurement and disclosure of outcome measures are commonly used policy tools in healthcare. The effectiveness of such disclosures relies on the extent to which the new information produced by the mandatory system is internalized by the healthcare... View Details

Keywords: Value Of Information; Feedback; Patient Satisfaction; Healthcare; Health Care and Treatment; Satisfaction; Information; Measurement and Metrics; Performance Improvement

Find at Harvard

September 2007
Case

Collaborating to Improve

By: Richard M.J. Bohmer and Ingrid M. Nembhard

Madison Memorial Hospital is deciding between a variety of quality improvement strategies. Highlights quality improvement collaborative—organized programs popularized by the Institute for Healthcare Improvement in which teams from multiple institutions work together to... View Details

Keywords: Health Care and Treatment; Service Delivery; Performance Improvement; Quality; Groups and Teams; Cooperation; Integration; Health Industry

19 Dec 2023
Research & Ideas

$15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy

$25,000 of annual revenue Private foundations After removing these and a few other special cases for which tax data were not available, we were left with 1,625 organizations. Of these, 1,190 organizations disclosed the size of their gifts. It is too soon to gauge the... View Details

Keywords: by Matthew Lee, Brian Trelstad, and Ethan Tran

Web

Faculty & Advisors | MBA

way clinical trials bottlenecked the development of new treatments for patients, compelling him to start TrialSpark. TrialSpark is a tech-driven drug development company that can run higher quality clinical trials at a fraction of the... View Details

15 Mar 2016
First Look

March 15, 2016

presidential and parliamentary elections shows that voter registration requirements have significant effects on turnout, disproportionately discouraging marginalized citizens. We assigned 20,500 apartments to one control or six View Details

March 2010 (Revised March 2014)
Case

Roll Back Malaria and BCG: The Change Initiative

By: Nava Ashraf, Rachel Gordon and Catherine Ross

Roll Back Malaria, a global partnership dedicated to fighting malaria has not met its founders' expectations of effectively combatting malaria. In 2005, after several internal evaluations, RBM leadership has decided to engage the Boston Consulting Group to work on a... View Details

Keywords: Health Care and Treatment; Management Practices and Processes; Performance Evaluation; Communication Strategy; Communication Intention and Meaning; Non-Governmental Organizations; Change Management; Multinational Firms and Management; Negotiation; Health Industry

January 2009
Case

When Supply is of Public Interest: Roche & Tamiflu

The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details

Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry